Oncolytic virus therapy is presented as a cancer immunotherapy modality with multifaceted mechanisms of tumor elimination.
First-pass extracted concept
oncolytic virus therapy
Aliases
OVs therapy, OV therapy
Extracted Explainers
What the tool is doing
What problem it solves
What it does not solve
Evidence Snippets
Supporting Sources
Linked Claims
The OV-phototherapy combination literature discussed in the source includes optical imaging-guided diagnosis and optogenetically controlled delivery applications.
It also explores their applications in optical imaging-guided diagnosis and optogenetically controlled delivery.
Phototherapy used in conjunction with oncolytic viruses can enhance viral delivery, amplify tumor destruction, and boost antitumor immune responses.
Phototherapy, an innovative and rapidly advancing cancer treatment technology, can mitigate these limitations when used in conjunction with OVs, enhancing viral delivery, amplifying tumor destruction, and boosting antitumor immune responses.
Combined OV-phototherapy strategies are promising in preclinical models but remain largely in early-stage research.
While promising in preclinical models, these combined strategies are still largely in early-stage research.
The efficacy of oncolytic virus therapy as a monotherapy is constrained by physiological barriers, limited delivery routes, and suboptimal immune activation.
However, its efficacy as a monotherapy remains constrained by physiological barriers, limited delivery routes, and suboptimal immune activation.
The review analyzes synergistic integration of oncolytic viruses with photodynamic therapy and photothermal therapy.
This review provides the first comprehensive analysis of synergistic integration of OVs with both photodynamic therapy (PDT) and photothermal therapy (PTT).
Oncolytic virus therapy is a promising modality in cancer immunotherapy.
Oncolytic virus (OVs) therapy has emerged as a promising modality in cancer immunotherapy
Clinical translation of combined OV-phototherapy strategies is limited by light penetration, delivery efficiency, and safety concerns.
Challenges such as limited light penetration, delivery efficiency, and safety concerns remain to be addressed for clinical translation.